TABLE I. Demographic and clinical characteristics of kidney transplant recipients (n = 207).

Age (years)	-	45 ± 12
Male gender [n (%)]	-	105 (51)
Donor [n (%)]	Living	108 (52)
	Cadaver	99 (48)
Type of dialysis [n (%)]	Haemodialysis	197 (95)
	Peritoneal dialysis	13 (6)
	None	4 (2)
Time on dialysis (months) (mean ± SD)	-	50 (± 42)
Min-max		0-156
Time transplanted (months) (mean ± SD)	-	82 (± 38)
Min-max		13-122
Transfusion [n (%)]	-	133 (64)
Drug injection user [n (%)]	-	3 (1)
HBV vaccination [n (%)]	Yes	130 (62)
	No	17 (9)
	Not available	60 (29)
Primary disease [n (%)]	Chronic glomerulonephritis	64 (31)
	Hypertensive nephropathy	43 (21)
	Diabetic nephropathy	16 (8)
	Undefined	55 (26)
	Others	29 (14)
Type of immunosuppression [n (%)]	Prednisone/sirolimus/MMF	71 (34)
	Prednisone/tacrolimus/MMF	42 (21)
	Sirolimus/MMF	29 (14)
	Others	65 (31)
Isolated anti-HBc [n (%)]	-	2 (1)
Anti-HBc + anti-HBs [n (%)]	-	10 (5)
Anti-HBs [n (%)]	-	114 (55)
Anti-HCV [n (%)]	-	25 (12)
ALT (IU/mL)	-	22
Elevated ALT [n (%)]	-	46 (22)
GGT (IU/mL) (median)	-	36
Elevated GGT [n (%)]	-	67 (32)
HBV-DNA (PCR) [n (%)]	-	2 (1)

ALT: alanine aminotransferase; GGT: gama-glutamyl transpeptidase; anti-HBc: hepatitis B core antibodies; anti-HBs: hepatitis B surface antibodies; HBV: hepatitis B virus; HCV: hepatitis C virus; MMF: mycophenolate mofetil; PCR: polymerase chain reaction; SD: standard deviation.